These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35264490)
1. [A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer]. Kashima H; Minami R; Ozawa T; Matsumoto A; Kimura Y; Takeda Y; Ueo T; Okano A; Kusumi F; Ohana M Nihon Shokakibyo Gakkai Zasshi; 2022; 119(3):259-266. PubMed ID: 35264490 [TBL] [Abstract][Full Text] [Related]
2. The use of eculizumab in gemcitabine induced thrombotic microangiopathy. Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518 [TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report]. Rogier T; Gerfaud-Valentin M; Pouteil-Noble C; Taleb A; Guillet M; Noel A; Broussolle C; Sève P Rev Med Interne; 2016 Oct; 37(10):701-704. PubMed ID: 26833144 [TBL] [Abstract][Full Text] [Related]
4. Microangiopathy associated with gemcitabine: a drug interaction with nab-paclitaxel? A case series and literature review. Allard J; Bonnet M; Laurent L; Bouattour M; Gagaille MP; Leclerc V Eur J Clin Pharmacol; 2022 Jul; 78(7):1087-1093. PubMed ID: 35507073 [TBL] [Abstract][Full Text] [Related]
5. Thrombotic Microangiopathy in a Patient Treated With Gemcitabine. Nanjappa S; Singh V; Uttamchandani S; Pabbathi S Cancer Control; 2017 Jan; 24(1):54-56. PubMed ID: 28178713 [TBL] [Abstract][Full Text] [Related]
6. [A Case of Effective Plasma Exchange for Thrombotic Microangiopathy during Chemotherapy for Pancreatic Cancer]. Yamashita M; Shimizu J; Sato Y; Odagiri K; Yanagimoto Y; Takeyama H; Suzuki Y; Ikenaga M; Kawase T; Imamura H; Akagi K; Iwasawa S; Tomita N; Dono K Gan To Kagaku Ryoho; 2022 Dec; 49(13):1959-1961. PubMed ID: 36733057 [TBL] [Abstract][Full Text] [Related]
7. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature. Burns ST; Damon L; Akagi N; Laszik Z; Ko AH Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643 [TBL] [Abstract][Full Text] [Related]
8. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report. Nishikubo M; Shimomura Y; Hiramoto N; Sawamura N; Yamaguchi T; Hara S; Ishikawa T BMC Nephrol; 2021 May; 22(1):175. PubMed ID: 33980166 [TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort. Daviet F; Rouby F; Poullin P; Moussi-Francès J; Sallée M; Burtey S; Mancini J; Duffaud F; Sabatier R; Pourroy B; Grandvuillemin A; Grange S; Frémeaux-Bacchi V; Coppo P; Micallef J; Jourde-Chiche N Br J Clin Pharmacol; 2019 Feb; 85(2):403-412. PubMed ID: 30394581 [TBL] [Abstract][Full Text] [Related]
11. Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel. Garcia de Herreros M; Esposito F; Sauri T; Font C J Oncol Pharm Pract; 2023 Apr; 29(3):738-745. PubMed ID: 35876362 [TBL] [Abstract][Full Text] [Related]
12. A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke. Phelan PJ; Liew A; Magee C Ren Fail; 2009; 31(8):743-4. PubMed ID: 19814643 [TBL] [Abstract][Full Text] [Related]
13. Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre. Grall M; Daviet F; Chiche NJ; Provot F; Presne C; Coindre JP; Pouteil-Noble C; Karras A; Guerrot D; François A; Benhamou Y; Veyradier A; Frémeaux-Bacchi V; Coppo P; Grangé S BMC Nephrol; 2021 Jul; 22(1):267. PubMed ID: 34284729 [TBL] [Abstract][Full Text] [Related]
14. [A Case of Pathological Complete Response Induced by Preoperative Chemotherapy with Gemcitabine plus Nab-Paclitaxel in a Patient with Pancreatic Cancer on Hemodialysis]. Okazaki M; Tajima H; Ohbatake Y; Terai S; Nakanuma S; Okamoto K; Sakai S; Makino I; Kinoshita J; Nakamura K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Ohta T Gan To Kagaku Ryoho; 2018 Dec; 45(13):2162-2164. PubMed ID: 30692318 [TBL] [Abstract][Full Text] [Related]
15. Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis. Thomas JG; Sethi S; Norby SM Am J Kidney Dis; 2011 May; 57(5):799-802. PubMed ID: 21411201 [TBL] [Abstract][Full Text] [Related]
16. [Thrombotic microangiopathy under an effective treatment with gemcitabine]. Finkenwirth P; Schick D; Horger MS; Fend F; Lauer UM; Gregor M; Bitzer M Z Gastroenterol; 2009 Mar; 47(3):288-91. PubMed ID: 19280543 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis. Kaneko T; Sugimori K; Tozuka Y; Fukushima T; Okada K; Oka H; Okazaki H; Maeda S Clin J Gastroenterol; 2019 Oct; 12(5):484-489. PubMed ID: 30993653 [TBL] [Abstract][Full Text] [Related]
18. Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer. Courtellemont C; Guitard J; Mehrenberger M; Pontier S; Ribes D; Kamar N; Esposito L; Modesto A; Rostaing L Clin Nephrol; 2007 Feb; 67(2):114-8. PubMed ID: 17338432 [TBL] [Abstract][Full Text] [Related]
19. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports . López Rubio ME; Rodado Martínez R; Illescas ML; Mateo Bosch E; Martinez Díaz M; de la Vara Inesta L; Cabezuelo B; Morales Albuja ME; Lucas Guillén E; Jimeno García L Clin Nephrol; 2017 Feb; 87 (2017)(2):100-106. PubMed ID: 27879189 [TBL] [Abstract][Full Text] [Related]
20. Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: A case report. Lai-Tiong F; Duval Y; Krabansky F Oncol Lett; 2017 Mar; 13(3):1201-1203. PubMed ID: 28454234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]